| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |